K. Wah Group
VC Fund
Hong Kong, Hong Kong
K. Wah Group is a VC fund in Hong Kong focused on Biopharma and Health Care. K. Wah Group is engaged in property development and investment, entertainment and resorts, hospitality, and construction materials. K. Wah Grou has over 200 subsidiaries, including two Hong Kong-listed flagships: K. Wah International Holdings Limited and Galaxy Entertainment Group Limited. Other major subsidiaries include Stanford HotelsInternational and K. Wah Construction Materials Limited.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries K. Wah Group invests in
Stages K. Wah Group invests in
Countries K. Wah Group invests in
Investment Focus
Industry
- Biopharma 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| The company has built a global level of bio-pharmaceutical research and development and industrialization platform; established for cancer, autoimmune diseases, inflammation and cardiovascular disease of the rich product line. The scale of the company's platform, hardware and software facilities, the number of new drug product lines, R &D team in the country are the same industry-leading level. Kang Fang biological has been with the international and domestic listed pharmaceutical companies to establish a cooperative relationship, the joint development of innovative antibodies to new drugs, is a strategic cooperation in the form of development of new drugs in the forerunner. | $150M / Series D / Nov 04, 2019 |
Co-Investors
Apricot Capital
1 deal together
BOCOM International
1 deal together
CCB Capital
1 deal together
Lake Bleu Capital
1 deal together
Loyal Valley Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does K. Wah Group invest in?
K. Wah Group invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Series D stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did K. Wah Group last invest?
The most recent investment recorded for K. Wah Group closed in Nov 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
